Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
 

Learn about the flu shot, COVID-19 vaccine, and our masking policy »

Stanford Health Care

Utilization of hepatitis C virus-infected organ donors in cardiothoracic transplantation: An ISHLT expert consensus statement. The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation Aslam, S., Grossi, P., Schlendorf, K. H., Holm, A. M., Woolley, A. E., Blumberg, E., Mehra, M. R. 2020; 39 (5): 418-432

Abstract

The advent of therapies for successful treatment of hepatitis C virus has allowed the heart and lung transplant community to re-explore the use of hepatitis C virus-positive donors for organ transplantation, with a benefit for many terminally ill patients. The consensus statements provided herein represent the current state of knowledge and expertise in this area, which we expect will continue to rapidly evolve over the next few years.

View details for DOI 10.1016/j.healun.2020.03.004

View details for PubMedID 32362393